title: Salbutamol-responsive fetal acetylcholine receptor inactivation syndrome.
authors.affiliation: From Evelina's Children Hospital (N.M.A., H.J.), Guy's & St. Thomas' Hospital NHS Foundation Trust, London; University of Oxford (Y.H., D.B., A.V.); John Radcliffe Hospital (J.P.), Oxford; and King's College (H.J.), London, UK.
authors.forename: Nicholas M
authors.initials: NM
authors.lastname: Allen
authors.affiliation: From Evelina's Children Hospital (N.M.A., H.J.), Guy's & St. Thomas' Hospital NHS Foundation Trust, London; University of Oxford (Y.H., D.B., A.V.); John Radcliffe Hospital (J.P.), Oxford; and King's College (H.J.), London, UK.
authors.forename: Yael
authors.initials: Y
authors.lastname: Hacohen
authors.affiliation: From Evelina's Children Hospital (N.M.A., H.J.), Guy's & St. Thomas' Hospital NHS Foundation Trust, London; University of Oxford (Y.H., D.B., A.V.); John Radcliffe Hospital (J.P.), Oxford; and King's College (H.J.), London, UK.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Palace
authors.affiliation: From Evelina's Children Hospital (N.M.A., H.J.), Guy's & St. Thomas' Hospital NHS Foundation Trust, London; University of Oxford (Y.H., D.B., A.V.); John Radcliffe Hospital (J.P.), Oxford; and King's College (H.J.), London, UK.
authors.forename: David
authors.initials: D
authors.lastname: Beeson
authors.affiliation: From Evelina's Children Hospital (N.M.A., H.J.), Guy's & St. Thomas' Hospital NHS Foundation Trust, London; University of Oxford (Y.H., D.B., A.V.); John Radcliffe Hospital (J.P.), Oxford; and King's College (H.J.), London, UK.
authors.forename: Angela
authors.initials: A
authors.lastname: Vincent
authors.affiliation: From Evelina's Children Hospital (N.M.A., H.J.), Guy's & St. Thomas' Hospital NHS Foundation Trust, London; University of Oxford (Y.H., D.B., A.V.); John Radcliffe Hospital (J.P.), Oxford; and King's College (H.J.), London, UK. heinz.jungbluth@gstt.nhs.uk.
authors.forename: Heinz
authors.initials: H
authors.lastname: Jungbluth
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D009468:Neuromuscular Diseases / Q000188:drug therapy*; D011978:Receptors, Nicotinic / Q000276:immunology; D013577:Syndrome
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; C539275:CHRNG protein, human; D009465:Neuromuscular Agents; D011978:Receptors, Nicotinic; D000420:Albuterol